Book contents
- Common Pitfalls in Multiple Sclerosis and CNS Demyelinating DiseasesCase-Based Learning
- Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases
- Copyright page
- Contents
- Preface
- Chapter 1 Pitfalls in identifying the classical clinical features of MS
- Chapter 2 Pitfalls in correctly assessing the clinical course of MS
- Chapter 3 Pitfalls in recognizing uncommon MS clinical presentations
- Chapter 4 Challenges in the therapeutic management of MS
- Chapter 5 Challenges in diagnosing demyelinating ocular disease
- Chapter 6 Pitfalls in diagnosing cerebral parenchymal disease
- Chapter 7 Pitfalls in diagnosing demyelinating cerebellar disease
- Chapter 8 Challenges in diagnosing demyelinating brainstem disease
- Chapter 9 Challenges in diagnosing spinal cord disease
- Index
- References
Chapter 6 - Pitfalls in diagnosing cerebral parenchymal disease
Published online by Cambridge University Press: 05 May 2016
Book contents
- Common Pitfalls in Multiple Sclerosis and CNS Demyelinating DiseasesCase-Based Learning
- Common Pitfalls in Multiple Sclerosis and CNS Demyelinating Diseases
- Copyright page
- Contents
- Preface
- Chapter 1 Pitfalls in identifying the classical clinical features of MS
- Chapter 2 Pitfalls in correctly assessing the clinical course of MS
- Chapter 3 Pitfalls in recognizing uncommon MS clinical presentations
- Chapter 4 Challenges in the therapeutic management of MS
- Chapter 5 Challenges in diagnosing demyelinating ocular disease
- Chapter 6 Pitfalls in diagnosing cerebral parenchymal disease
- Chapter 7 Pitfalls in diagnosing demyelinating cerebellar disease
- Chapter 8 Challenges in diagnosing demyelinating brainstem disease
- Chapter 9 Challenges in diagnosing spinal cord disease
- Index
- References
- Type
- Chapter
- Information
- Common Pitfalls in Multiple Sclerosis and CNS Demyelinating DiseasesCase-Based Learning, pp. 50 - 63Publisher: Cambridge University PressPrint publication year: 2016
References
Further reading
Staff, NP, Lucchinetti, CF, Keegan, BM. Multiple sclerosis with predominant, severe cognitive impairment. Arch Neurol 2009;66:1139–43.CrossRefGoogle ScholarPubMed
Kokmen, E, Naessens, J, Offord, K. A short test of mental status: Description and preliminary results. Mayo Clin Proc 1987;62:281–8.CrossRefGoogle Scholar
Zarei, M, Chandran, S, Compston, A, Hodges, J. Cognitive presentation of multiple sclerosis: evidence for a cortical variant. Journal of Neurology, Neurosurgery & Psychiatry 2003;74:872–7.CrossRefGoogle ScholarPubMed
Rao, SM, Leo, GJ, Bernardin, L, Unverzagt, F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685–91.Google ScholarPubMed
Keegan, BM, Giannini, C, Parisi, JE, Lucchinetti, CF, Boeve, BF, Josephs, KA. Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology 2008;70:1128–33.CrossRefGoogle ScholarPubMed
Mateen, FJ, Keegan, BM, Krecke, K, Parisi, JE, Trenerry, MR, Pittock, SJ. Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study. Journal of neurology, neurosurgery, and psychiatry 2010;81:619–22.CrossRefGoogle ScholarPubMed
Fleming, JO, Keegan, BM, Parisi, JE. A 52-year-old man with progressive left-sided weakness and white matter disease. Neurology 2007;69:600–6.CrossRefGoogle ScholarPubMed
Padiath, QS, Fu, YH. Autosomal dominant leukodystrophy caused by lamin B1 duplications a clinical and molecular case study of altered nuclear function and disease. Methods Cell Biol 2010;98:337–57.CrossRefGoogle ScholarPubMed
Dalmau, J, Lancaster, E, Martinez-Hernandez, E, Rosenfeld, MR, Balice-Gordon, R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63–74.CrossRefGoogle ScholarPubMed
Lin, ST, Ptacek, LJ, Fu, YH. Adult-onset autosomal dominant leukodystrophy: linking nuclear envelope to myelin. J Neurosci 2011;31:1163–6.CrossRefGoogle ScholarPubMed
Rademakers, R, Baker, M, Nicholson, AM, et al. Mutations in the colony stimulating factor 1 receptor (CSF1 R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 2012;44:200–5.CrossRefGoogle Scholar
Jones, KC, Benseler, SM, Moharir, M. Anti-NMDA Receptor Encephalitis. Neuroimaging Clin N Am 2013;23:309–20.CrossRefGoogle ScholarPubMed
Nicholson, AM, Baker, MC, Finch, NA, et al. CSF1 R mutations link POLD and HDLS as a single disease entity. Neurology 2013;80:1033–40.CrossRefGoogle Scholar
Kronenburg, A, Braun, KP, van der Zwan, A, Klijn, CJ. Recent advances in moyamoya disease: pathophysiology and treatment. Curr Neurol Neurosci Rep 2014;14:423.CrossRefGoogle ScholarPubMed
Chabriat, H, Joutel, A, Dichgans, M, Tournier-Lasserve, E, Bousser, MG. Cadasil. Lancet Neurol 2009;8:643–53.CrossRefGoogle ScholarPubMed
Constantinescu, CS, McConachie, NS, White, BD. Corpus callosum changes following shunting for hydrocephalus: case report and review of the literature. Clin Neurol Neurosurg 2005;107:351–4.CrossRefGoogle ScholarPubMed
Lane, JI, Luetmer, PH, Atkinson, JL. Corpus callosal signal changes in patients with obstructive hydrocephalus after ventriculoperitoneal shunting. AJNR Am J Neuroradiol 2001;22:158–62.Google ScholarPubMed